Zgliczyńska-Widłak J
Klinika Endokrynologii i Centralna Konsultacyjna Poradnia Endokrynologii CMKP, Szpital Bielański, Warszawa.
Endokrynol Pol. 1992;43(3):298-307.
To compare an efficacy of the galenic form of desiccated thyroid gland--Thyreoideum "Polfa" with the synthetic L-thyroxine (Eltroxin Glaxo) in the treatment of hypothyroidism 15 patients were investigated. In all 15 cases before and after treatment ECG and the serum concentrations of cholesterol, thyroxine (T4), triiodothyronine (T3) as well as thyrotropin (TSH) in response to TRH were performed. After the treatment with Thyreoideum "Polfa" in doses 0.2 to 0.6 mg/daily there were neither clinical improvement, normalization of ECG, the serum concentrations of cholesterol, T3, T4 nor TSH. However, after the L-thyroxine treatment (Eltroxin Glaxo) in doses 100 to 200 micrograms/daily the clinical signs of hypothyroidism disappeared in all 15 patients. In ECG the statistically significant increase in voltage of the R and T waves after L-thyroxine treatment were observed. Also a significant decrease in the serum concentration of cholesterol and an increase in T4 and T3 were found. The serum concentration of TSH in response to TRH after the L-thyroxine treatment significantly decreased. L-thyroxine appeared to be a very efficacious in the treatment either primary or secondary hypothyroidism.
为比较干燥甲状腺制剂“Polfa”甲状腺片与合成L-甲状腺素(葛兰素史克公司的优甲乐)治疗甲状腺功能减退症的疗效,对15例患者进行了研究。在所有15例患者治疗前后均进行了心电图检查以及测定了胆固醇、甲状腺素(T4)、三碘甲状腺原氨酸(T3)的血清浓度以及促甲状腺激素(TSH)对促甲状腺激素释放激素(TRH)的反应。在用剂量为0.2至0.6毫克/天的“Polfa”甲状腺片治疗后,既没有临床改善,心电图、胆固醇、T3、T4的血清浓度以及TSH也未恢复正常。然而,在用剂量为100至200微克/天的L-甲状腺素(葛兰素史克公司的优甲乐)治疗后,所有15例患者甲状腺功能减退的临床症状均消失。在心电图方面,观察到L-甲状腺素治疗后R波和T波电压有统计学意义的升高。还发现胆固醇血清浓度显著降低,T4和T3升高。L-甲状腺素治疗后TSH对TRH反应的血清浓度显著降低。L-甲状腺素似乎对原发性或继发性甲状腺功能减退症的治疗都非常有效。